Jianmin Pharmaceutical Group Co Ltd (600976) — Cash Flow Reinvestment Rate
Jianmin Pharmaceutical Group Co Ltd (600976) has a Cash Flow Reinvestment Rate of 0.36x as of December 2025, reinvesting CN¥38.21 Million (capex CN¥23.23 Million plus investments CN¥-14.98 Million) from operating cash flow of CN¥106.82 Million. Check 600976 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Jianmin Pharmaceutical Group Co Ltd Cash Flow Reinvestment Rate (2003–2025)
Historical reinvestment intensity for Jianmin Pharmaceutical Group Co Ltd across 20 annual periods. Explore 600976 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Jianmin Pharmaceutical Group Co Ltd (2003–2025)
Year-by-year capital reinvestment analysis for Jianmin Pharmaceutical Group Co Ltd. For live market cap and broader valuation context, see 600976 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.42x | CN¥114.34 Million | CN¥274.53 Million | CN¥100.67 Million | ▼ -70.2% |
| 2024 | 1.40x | CN¥327.06 Million | CN¥234.27 Million | CN¥120.29 Million | ▲ +164.2% |
| 2023 | 0.53x | CN¥141.81 Million | CN¥268.39 Million | CN¥64.50 Million | ▼ -20.5% |
| 2022 | 0.66x | CN¥143.44 Million | CN¥215.87 Million | CN¥67.96 Million | ▲ +45.5% |
| 2021 | 0.46x | CN¥118.37 Million | CN¥259.18 Million | CN¥55.99 Million | ▼ -67.0% |
| 2020 | 1.38x | CN¥173.75 Million | CN¥125.54 Million | CN¥45.58 Million | ▼ -28.2% |
| 2019 | 1.93x | CN¥143.57 Million | CN¥74.45 Million | CN¥69.31 Million | ▼ -10.4% |
| 2018 | 2.15x | CN¥136.82 Million | CN¥63.60 Million | CN¥42.37 Million | ▼ -62.3% |
| 2017 | 5.71x | CN¥200.93 Million | CN¥35.20 Million | CN¥41.93 Million | ▲ +448.5% |
| 2016 | 1.04x | CN¥118.48 Million | CN¥113.84 Million | CN¥29.42 Million | ▼ -51.3% |
| 2015 | 2.14x | CN¥103.55 Million | CN¥48.45 Million | CN¥29.75 Million | ▲ +724.1% |
| 2014 | 0.26x | CN¥26.77 Million | CN¥103.23 Million | CN¥26.77 Million | ▼ -50.8% |
| 2013 | 0.53x | CN¥23.90 Million | CN¥45.36 Million | CN¥23.90 Million | ▲ +476.8% |
| 2012 | 0.09x | CN¥8.97 Million | CN¥98.17 Million | CN¥8.97 Million | ▲ +153.3% |
| 2010 | 0.04x | CN¥5.41 Million | CN¥150.08 Million | CN¥5.41 Million | ▼ -83.4% |
| 2009 | 0.22x | CN¥14.50 Million | CN¥66.69 Million | CN¥14.50 Million | ▲ +175.5% |
| 2008 | 0.08x | CN¥8.69 Million | CN¥110.11 Million | CN¥8.69 Million | ▼ -73.3% |
| 2006 | 0.30x | CN¥16.61 Million | CN¥56.18 Million | CN¥16.61 Million | ▼ -97.9% |
| 2004 | 13.95x | CN¥57.64 Million | CN¥4.13 Million | CN¥57.64 Million | ▼ -40.3% |
| 2003 | 23.37x | CN¥97.88 Million | CN¥4.19 Million | CN¥97.88 Million | — |